Oxygenta Pharmaceutical Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

With reference to the cited subject, this is to certify that the details of Securities dematerialized/ rematerialized during the quarter ended 30th June, 2022 as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the Stock exchange where the shares of the Company is listed. The letter dated 04th July, 2022 received from Venture Capital and Corporate Investments Private Limited (RTA) confirming the same is enclosed for your reference. Kindly take the same on record and acknowledge the receipt of the same.